标题
New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship
作者
关键词
-
出版物
DRUGS
Volume 79, Issue 7, Pages 705-714
出版商
Springer Science and Business Media LLC
发表日期
2019-04-11
DOI
10.1007/s40265-019-01112-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Omadacycline for Community-Acquired Bacterial Pneumonia
- (2019) Roman Stets et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
- (2019) William O’Riordan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
- (2018) Lynn E. Connolly et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections
- (2018) F. Wagenlehner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
- (2018) Ronald Domalaon et al. CLINICAL MICROBIOLOGY REVIEWS
- Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria
- (2018) Lindsay M. Avery et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Novel pharmacotherapy for the treatment of hospital-acquired and ventilator-associated pneumonia caused by resistant gram-negative bacteria
- (2018) James M. Kidd et al. EXPERT OPINION ON PHARMACOTHERAPY
- Review and Mapping of Carbapenem-resistant Enterobacteriaceae in Africa: Using Diverse Data to Inform Surveillance Gaps
- (2018) Elizabeth A. Mitgang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii
- (2018) Harald Seifert et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Murepavadin activity tested against contemporary (2016–17) clinical isolates of XDR Pseudomonas aeruginosa
- (2018) Helio S Sader et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Predominance of methicillin-resistant Staphylococcus aureus in the residents and environments of long-term care facilities in Taiwan
- (2018) Chia-Ying Liu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial
- (2018) Antoni Torres et al. LANCET INFECTIOUS DISEASES
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections
- (2018) Sohita Dhillon DRUGS
- Optimized arylomycins are a new class of Gram-negative antibiotics
- (2018) Peter A. Smith et al. NATURE
- Omadacycline: First Global Approval
- (2018) Anthony Markham et al. DRUGS
- CLINICAL CHARACTERISTICS AND PROGNOSIS OF INFECTIONS CAUSED BY OXA-48 CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE IN PATIENTS TREATED WITH CEFTAZIDIME-AVIBACTAM
- (2018) C. De la Calle et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
- (2018) Shun-Chung Hsueh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
- (2018) Simon Portsmouth et al. LANCET INFECTIOUS DISEASES
- In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
- (2018) Shio-Shin Jean et al. Infection and Drug Resistance
- 1370. Cefepime/VNRX-5133 Broad-Spectrum Activity Is Maintained Against Emerging KPC- and PDC-Variants in Multidrug-Resistant K. pneumoniae and P. aeruginosa
- (2018) Denis Daigle et al. Open Forum Infectious Diseases
- Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens
- (2017) J. Dobias et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- In-vitro activity of several antimicrobial agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates expressing aminoglycoside-modifying enzymes: potency of plazomicin alone and in combination with other agents
- (2017) María Carmen López Díaz et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections
- (2017) Matthew Sims et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study
- (2017) J Pullman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria
- (2017) David M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae
- (2017) Virginia M. Pierce et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan
- (2017) Sung-Pin Tseng et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems
- (2017) Chia-Hsin Lee et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan
- (2017) Chun-Ming Lee et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance
- (2017) Yee-Huang Ku et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria
- (2017) Pooi Yin Chung et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial
- (2017) Joseph Solomkin et al. JAMA Surgery
- Plazomicin Vs. Meropenem for Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP): Diagnosis-specific Results From the Phase 3 EPIC Study
- (2017) Daniel J Cloutier et al. Open Forum Infectious Diseases
- Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
- (2016) Christopher Lucasti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
- (2016) Robert K. Flamm et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, for Dose Adjustment Based on Renal Function
- (2016) Takayuki Katsube et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
- (2016) Tamar F. Barlam et al. CLINICAL INFECTIOUS DISEASES
- Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms
- (2016) Roopali Sharma et al. CLINICAL THERAPEUTICS
- Treatment options for infections caused by carbapenem-resistantEnterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy?
- (2016) Federico Perez et al. EXPERT OPINION ON PHARMACOTHERAPY
- The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?
- (2016) Matthew E. Falagas et al. Expert Review of Anti-Infective Therapy
- New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance
- (2016) Ling-Shan Syue et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008–14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
- (2016) Shio-Shin Jean et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections
- (2016) Marco Falcone et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae
- (2016) Darren Wong et al. Virulence
- Adjuvants Based on Hybrid Antibiotics Overcome Resistance in Pseudomonas aeruginosa and Enhance Fluoroquinolone Efficacy
- (2015) Bala Kishan Gorityala et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options
- (2015) Shio-Shin Jean et al. Future Microbiology
- In vitro activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa and Enterobacteriaceae recovered in Spanish medical centres: Results of the CENIT study
- (2015) Marta Tato et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases
- (2015) David M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phase I, Open-Label, Safety and Pharmacokinetic Study To Assess Bronchopulmonary Disposition of Intravenous Eravacycline in Healthy Men and Women
- (2014) Kevin P. Connors et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae
- (2013) Milena McLaughlin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Organisms Collected from U.S. Medical Centers in 2012
- (2013) Helio S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Ceftaroline-Avibactam Tested against Gram-Negative Organism Populations, including Strains Expressing One or More β-Lactamases and Methicillin-Resistant Staphylococcus aureus Carrying Various Staphylococcal Cassette ChromosomemecTypes
- (2012) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Action of the Arylomycin Antibiotics and Effects of Signal Peptidase I Inhibition
- (2012) Peter A. Smith et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization
- (2012) J. M. Remy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
- (2010) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More